pH/ATP cascade-responsive nano-courier with efficient tumor targeting and siRNA unloading for photothermal-immunotherapy
Source abstract
Abstract
Abstract Tumor delivery of programmed death-ligand 1 (PD-L1) siRNA is promising to enhance photothermal therapy (PTT) caused anti-tumor immunity. However, the poor tumor targeting efficiency and insufficient gene release in tumor cells restrict curative effect. Herein, phenylboronic acid (PBA)-based tumor targeting and rapid gene release nano-courier is constructed by encapsulating PD-L1 siRNA (siP) and IR780 (a photothermal agent) in pH/ATP cascade-responsive micelle. The nano-courier can be detached long-circulating PEG shell in a weakly acidic tumor microenvironment, resulting in increased positive charge and PBA exposure for facilitating the penetration and uptake of nano-courier against tumors with overexpressed sialic acid (SA) residues. Subsequently, the intracellular ATP binding with PBA reducing the positive charge of nano-courier could effectively trigger rapid uploading of siP into cytosol. Both in vitro and in vivo studies proved the nano-courier has good performance on PD-L1 silencing on tumor cells. PTT with systemic antitumor immune responses triggered by efficient PD-L1 silencing completely ablated 4T1 orthotopic tumor, suppressed distant tumors growth and metastasis as well as reduced the tumor recurrence.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Near-infrared-light-activatable nanomaterial-mediated phototheranostic nanomedicines: an emerging paradigm for cancer treatment10.1002/adma.201706320 ↗
2. Activating antitumor immunity and antimetastatic effect through polydopamine‐encapsulated core–shell upconversion nanoparticles10.1002/adma.201905825 ↗
3. Size/charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration10.1002/adfm.201707249 ↗
4. Activating antitumor immunity and antimetastatic effect through polydopamine‐encapsulated core–shell upconversion nanoparticles10.1002/adma.201905825 ↗
5. Tumor‐targeted drug and CpG delivery system for phototherapy and docetaxel‐enhanced immunotherapy with polarization toward M1‐type macrophages on triple negative breast cancers10.1002/adma.201904997 ↗
6. Regulation and function of the PD-L1 checkpoint10.1016/j.immuni.2018.03.014 ↗
7. Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance10.1038/nature25015 ↗
8. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity10.1038/ncomms12632 ↗
9. Palmitoylation stabilizes PD-L1 to promote breast tumor growth10.1038/s41422-018-0124-5 ↗
10. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
11. Factors affecting the clearance and biodistribution of polymeric nanoparticles10.1021/mp800051m ↗
12. Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery10.1002/adma.201903637 ↗
13. A reduction and pH dual-sensitive polymeric vector for long-circulating and tumor-targeted siRNA delivery10.1002/adma.201403877 ↗
14. Tumor-microenvironment-adaptive nanoparticles codeliver paclitaxel and siRNA to inhibit growth and lung metastasis of breast cancer10.1002/adfm.201601703 ↗
15. Tumor acidity-sensitive polymeric vector for active targeted siRNA delivery10.1021/jacs.5b09602 ↗
16. Charge and assembly reversible micelles fueled by intracellular ATP for improved siRNA transfection10.1021/acsami.8b13300 ↗
17. Near-infrared light-responsive intracellular drug and siRNA release using Au nanoensembles with oligonucleotide-capped silica shell10.1002/adma.201200785 ↗
18. Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment
19. Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy10.1016/j.biomaterials.2015.10.022 ↗
20. Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors10.1021/ja406406h ↗
21. Biomolecular robotics for chemomechanically driven guest delivery fuelled by intracellular ATP10.1038/nchem.1681 ↗
22. Enhanced melanoma-targeted therapy by “Fru-Blocked” phenyboronic acid-modified multiphase antimetastatic micellar nanoparticles
23. Systemic siRNA delivery with a dual pH-responsive and tumor-targeted nanovector for inhibiting tumor growth and spontaneous metastasis in orthotopic murine model of breast carcinoma10.7150/thno.16855 ↗
24. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy10.1038/s41565-019-0485-z ↗
25. ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy10.7150/thno.26889 ↗
26. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
27. Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy10.2147/IJN.S106073 ↗
28. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy10.1039/C8NR01184B ↗
29. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting10.1016/j.biomaterials.2014.02.031 ↗
30. Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration10.1016/j.addr.2017.07.021 ↗
31. Physiological concentrations of purines and pyrimidines10.1007/BF00928361 ↗
32. ATP-triggered anticancer drug delivery10.1038/ncomms4364 ↗
33. Live cell imaging of duplex siRNA intracellular trafficking10.1093/nar/gkv307 ↗
34. Enhanced intracellular delivery of siRNA by controlling ATP‐responsivity of phenylboronic acid‐functionalized polyion complex micelles
35. Nanoparticles - a review10.4314/tjpr.v5i1.14634 ↗
36. Progress of drug-loaded polymeric micelles into clinical studies10.1016/j.jconrel.2014.06.042 ↗
37. Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel10.1016/j.biomaterials.2015.01.049 ↗
38. Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation10.1080/02656730500271692 ↗
39. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer10.1038/s41467-018-03473-9 ↗
40. Photosensitizer micelles together with IDO inhibitor enhance cancer photothermal therapy and immunotherapy
41. The two faces of interferon-γ in cancer10.1158/1078-0432.CCR-11-0482 ↗
42. Enhanced tumor retention effect by click chemistry for improved cancer immunochemotherapy10.1021/acsami.8b02954 ↗
43. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy10.1038/ncomms13193 ↗
44. Lineage relationship and protective immunity of memory CD8 T cell subsets10.1038/ni889 ↗
45. PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment10.1016/j.ejps.2018.10.021 ↗